Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2015. Start Trial.
Date Value
October 23, 2026 0.6014
October 22, 2026 0.6093
October 21, 2026 0.6146
October 20, 2026 0.6119
October 19, 2026 0.6251
October 16, 2026 0.6303
October 15, 2026 0.633
October 14, 2026 0.6487
October 13, 2026 0.6487
October 12, 2026 0.6724
October 09, 2026 0.6671
October 08, 2026 0.6645
October 07, 2026 0.6645
October 06, 2026 0.6566
October 05, 2026 0.6645
October 02, 2026 0.6724
October 01, 2026 0.6776
September 30, 2026 0.6724
September 29, 2026 0.6829
September 28, 2026 0.7012
September 25, 2026 0.6907
September 24, 2026 0.7012
September 23, 2026 0.6881
September 22, 2026 0.7117
September 21, 2026 0.7039
Date Value
September 18, 2026 0.7249
September 17, 2026 0.7012
September 16, 2026 0.6829
September 15, 2026 0.6829
September 14, 2026 0.696
September 11, 2026 0.696
September 10, 2026 0.6776
September 09, 2026 0.654
September 08, 2026 0.6592
September 04, 2026 0.6697
September 03, 2026 0.6697
September 02, 2026 0.6802
September 01, 2026 0.6592
August 31, 2026 0.6592
August 28, 2026 0.6881
August 27, 2026 0.6986
August 26, 2026 0.6802
August 25, 2026 0.6802
August 24, 2026 0.7223
August 21, 2026 0.6986
August 20, 2026 0.6881
August 19, 2026 0.6829
August 18, 2026 0.6802
August 17, 2026 0.6802
August 14, 2026 0.6697

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 2.793
Corcept Therapeutics, Inc. 13.13
Veru, Inc. 1.346
Johnson & Johnson 7.789
Eli Lilly & Co. 35.39

Price to Book Value Related Metrics

Price 2.29
Earnings Yield -115.4%
Market Cap 10.14M